Schedule 13G ownership disclosure
Capricor Therapeutics Inc
Common Stock · CUSIP: 14070B309
Event date: 2024-12-31
- Filing-level shares
- 2,276,784
- Percent of class
- 5%
- The Vanguard Group
Shares: 2,276,784 · Class: 5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000932471-25-000133
- Form type
- SCHEDULE 13G
- Filer
- CAPRICOR THERAPEUTICS, INC.
- CIK
- CIK 1133869
- Filed
- Jan 30, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership